QR-Code

Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An in silico study

The current crisis of the COVID-19 pandemic around the world has been devastating as many lives have been lost to the novel SARS CoV-2 virus. Thus, there is an urgent need for the right therapeutic drug to curb the disease. However, there is time constraint in drug development, hence the need for dr...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Alfred Olaoluwa Akinlalu, Annapoorna Chamundi, Donald Terseer Yakumbur, Funmilayo I. Deborah Afolayan, Ijeoma Akunna Duru, Michael Aderibigbe Arowosegbe, Ojochenemi Aladi Enejoh
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2021-09-01
Schriftenreihe:Scientific African
Schlagworte:
Drug repurposing
COVID-19
In silico methods
Target-based docking
Online-Zugang:http://www.sciencedirect.com/science/article/pii/S2468227621001496
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge